DMRA Damora Therapeutics, Inc.
Company Analysis
Latest News
Damora Therapeutics Shareholders Approve All Proposals at 2026 Annual Meeting
Damora Therapeutics, Inc. announced the voting results from its 2026 Annual Meeting of Stockholders held on June 17, 2026. Shareholders approved all proposals...
🟢 Damora Therapeutics, Inc. is trading 5.3% up today amid bullish analyst initiations and institutional interest
Damora Therapeutics, Inc. is trading 5.3% up now at $21.68, extending a volatile but generally positive run over the past week. • Wall Street sentiment has...
🟢 Damora Therapeutics, Inc. is trading 5.9% up today after HC Wainwright initiated coverage with a Buy rating
Damora Therapeutics, Inc. is trading 5.9% up today at $21.34 following bullish analyst coverage and price targets significantly higher than current levels. •...
🔴 Damora Therapeutics, Inc. is trading 5.92% down today amid broader market weakness and risk-off sentiment
Damora Therapeutics, Inc. is trading at $19.72 (-5.92%) today following a sharp intraday drop that appears consistent with broader market weakness rather than...
🟢 Damora Therapeutics, Inc. is trading 5.55% up today after TD Cowen initiated coverage with a Buy rating
Damora Therapeutics, Inc. is trading at $22.07 (+5.55%) after TD Cowen initiated coverage with a Buy rating on June 8, 2026. • The move follows renewed...
Damora Therapeutics earns TD Cowen Buy rating, targeting rare blood disorders
TD Cowen initiated coverage of Damora Therapeutics (NASDAQ: DMRA) with a Buy rating on June 8, 2026. The firm cited confidence in the biotechnology company’s...
🔴 Damora Therapeutics, Inc. is trading 5.4% down today amid a broader pullback in high-growth biotech
Damora Therapeutics, Inc. is trading 5.4% down at $21.11 amid a broader pullback in high-growth, small-cap biotech names. • The drop extends a multi-day slide...
🔴 Damora Therapeutics, Inc. is trading 5.6% down today as risk-off sentiment hits small-cap biotech
Damora Therapeutics, Inc. is trading 5.6% down at $21.09 as risk-off sentiment pressures smaller biotechnology names and high-growth risk assets. • The stock...
🔴 Damora Therapeutics, Inc. is trading 5.4% down today, extending a multi-day slide amid biotech volatility
Damora Therapeutics, Inc. is trading 5.4% down at $21.12 today, extending a multi-day slide from recent closes above $24 amid broader volatility in the...
🔴 Damora Therapeutics, Inc. is trading 5.1% down today with no clear catalyst
Damora Therapeutics, Inc. is trading 5.1% down at $23.59 today, as the stock experiences an idiosyncratic move with no clear company-specific catalyst to...
Damora Therapeutics Lands $66 Million Stake Following 700% Stock Surge
FCPM III Services B.V. disclosed a new $65.6 million stake in Damora Therapeutics. The investment fund acquired 2,441,000 shares as of March 31, 2026. This...